Multiple Primary Cancers in North Tunisia, 2000 - 2009

Background and Objective: To evaluate and report the frequency, epidemiologic and anatomic - clinical features of patients who developed MPM from the data of North Tunisia Cancer Registry, during the period 2000-2009. Materials and methods: From a population of 53757 new patients of the North Tunisi...

Full description

Saved in:
Bibliographic Details
Published inAsian Pacific journal of cancer care Vol. 3; no. 3; p. 59
Main Authors Wided Ben Ayoub, Hajer Ben Khadhra, Hyem Khiari, Mansour Ben Abdallah, Hamouda Boussen, Mohamed Hsairi
Format Journal Article
LanguageEnglish
Published West Asia Organization for Cancer Prevention 01.09.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background and Objective: To evaluate and report the frequency, epidemiologic and anatomic - clinical features of patients who developed MPM from the data of North Tunisia Cancer Registry, during the period 2000-2009. Materials and methods: From a population of 53757 new patients of the North Tunisia National Cancer Registry database presenting new cases of cancers during the period 2000-2009 in North Tunisia, we collected and analyzed those with MPMTs. We used for MPMT the international IARC diagnosis criteria are published in ICD-O Third Edition. Results: In the 53757 new cancer cases registered from 2000-2009, we collected 528 cases (1.0%) of MPM. Mean age at diagnosis of the 1st cancer was 61 years (22-99) and sex-ratio at 1.08 (275M/253F) while mean age at the 2nd cancer diagnosis was 62 years(29 to 99). Among the 528 cases, the most frequent 1 st cancer site was breast in females (147 pts, 58.1%) and urinary tract for males (56 patients, 20.4%). In the 528 MPM cases, 321 (60.8%) were synchronous and 207 cases (39.2%) were metachronous tumors. The median time from 1 st to 2 nd cancer was 1.98 months (range 0-140). The most associated 1 st -2 nd cancer sites were breast in 110 patients (43.3%) in females and for males' urinary tract -prostate cancers (45 patients, 16.3%). Conclusions: The coexistence of a synchronous or metachronous MPM is possible and have to be considered during pretreatment evaluation. A close follow-up should be recommended to detect second malignancies in patients treated for a 1 st cancer.
ISSN:2588-3682
DOI:10.31557/apjcc.2018.3.3.59